“Imidex is deploying our leading FDA 510 (k) cleared algorithm for lung nodule and mass detection to improve the screening of potential future lung cancer patients,” said Wes Bolsen, CEO of Imidex.

IMOU Launches Next-Generation Smart Home A.I. With IMOU SENSE, The Self-Developed Advanced Algorithm Matrix Date 4/20/2023 4:16:40 AM MENAFN HANGZHOU, China, April 20, 2023 /PRNewswire/ -- ...